daxibotulinumtoxina-lanm

daxibotulinumtoxina-lanm (DAXXIFY) is an FDA-listed pharmaceutical active ingredient. Route of administration: intramuscular, subcutaneous. Current US regulatory status: approved.

DAXXIFY is a marketed brand name for daxibotulinumtoxina-lanm. Check FDA Drugs@FDA for the current US label holder and prescribing information.

daxibotulinumtoxina-lanm has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.